# Blistex Inc, Oak Brook, IL – FDA Inspections

Source: https://www.keypedia.com/companies/blistex-inc/5268fd01-ac61-4bf8-a1ca-192da45c825a

> Inspection records and compliance data for Blistex Inc in Oak Brook, Illinois. 7 FDA inspections on record, 1 Form 483, last inspected May 01, 2025.

---

## Details

- Name: Blistex Inc
- FEI Number: 1413077
- Address Line 1: 1800 Swift Dr
- City: Oak Brook
- State: Illinois
- Zip Code: 60523
- Country Name: United States
- Address: 1800 Swift Dr, Oak Brook, Illinois 60523, United States
- Country: United States

## Related Documents

- [483 - Blistex Inc - 2025-05-01](https://www.keypedia.com/records/483/blistex-inc/3b79c323-8ee9-45d5-bff7-b8d23ef924b5) — source: FDA, date: May 1, 2025
- [FDA Inspection 1264747 - Blistex Inc - 2025-05-01](https://www.keypedia.com/records/fda_inspections/blistex-inc/c7ad09a1-836d-415f-b106-ae3e6b4a02a7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 1, 2025
- FDA Inspection 1054757 - Blistex Inc - 2018-05-10 — classification: No Action Indicated (NAI), source: FDA, date: May 10, 2018
- FDA Inspection 919466 - Blistex Inc - 2015-03-26 — classification: No Action Indicated (NAI), source: FDA, date: March 26, 2015
- [FDA Inspection 919466 - Blistex Inc - 2015-03-26](https://www.keypedia.com/records/fda_inspections/blistex-inc/d9c7ea1d-1812-4705-b0ea-c1c66c309f87) — classification: No Action Indicated (NAI), source: FDA, date: March 26, 2015
- [FDA Inspection 797008 - Blistex Inc - 2012-08-31](https://www.keypedia.com/records/fda_inspections/blistex-inc/40561902-6d03-4484-930f-b7fea6d19041) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 31, 2012
- FDA Inspection 723895 - Blistex Inc - 2011-05-10 — classification: No Action Indicated (NAI), source: FDA, date: May 10, 2011
- FDA Inspection 723895 - Blistex Inc - 2011-05-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 10, 2011
- [FDA Inspection 653105 - Blistex Inc - 2010-03-19](https://www.keypedia.com/records/fda_inspections/blistex-inc/af5113c1-c563-4b4c-a3c3-cc3b97a41035) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 19, 2010
- [FDA Inspection 606556 - Blistex Inc - 2009-08-14](https://www.keypedia.com/records/fda_inspections/blistex-inc/cf55dd0c-3af0-40ce-8495-42db45719009) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 14, 2009

## Related Companies

- [Shire Human Genetic Therapies, Inc.](https://www.keypedia.com/companies/shire-human-genetic-therapies-inc/7051823d-8cc7-4d72-8a82-a0de9bbb9497)
- [Alkermes Inc](https://www.keypedia.com/companies/alkermes-inc/c20f3273-400d-4b2e-a485-214b986ed7c2)
- [Murty Pharmaceuticals, Inc](https://www.keypedia.com/companies/murty-pharmaceuticals-inc/8d7f8024-f6fd-463e-b94f-63cd3b745e96)
- [Tedor Pharma, Inc.](https://www.keypedia.com/companies/tedor-pharma-inc/a9fa17c4-23c1-4bcf-ad03-bb9635bb063d)
- [MW Encap Ltd.(NextPharma Edinburgh)](https://www.keypedia.com/companies/mw-encap-ltdnextpharma-edinburgh/e8cf1af5-d17a-4c79-ba7d-498a371fbc50)
- [Catalent Germany Eberbach GmbH](https://www.keypedia.com/companies/catalent-germany-eberbach-gmbh/fcf97f2a-c54b-4105-afc0-11a0c999d8a5)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/0de1df3a-c70c-43b9-9a35-4aac9b0413f4)
- [Vertex Pharmaceuticals Incorporated](https://www.keypedia.com/companies/vertex-pharmaceuticals-incorporated/f2bc62b8-1ece-42d2-b058-39466a256c74)
- [Playtex Manufacturing, Inc. - Plant #2](https://www.keypedia.com/companies/playtex-manufacturing-inc-plant-2/84ec69a6-5886-459c-b12a-e1e20a549c4f)
- [Rockledge Pharmaceutical Manufacturing LLC](https://www.keypedia.com/companies/rockledge-pharmaceutical-manufacturing-llc/a5456e96-65d2-4f19-ba2f-e7cb72b32922)

## Related Officers

- [Angela C. Welker](https://www.keypedia.com/people/angela-c-welker/b732b19f-c8e8-43b0-bc81-8dcde8a53c84)
- [Ramia Brzenjy](https://www.keypedia.com/people/ramia-brzenjy/b0e5e3b0-c295-4ec6-845a-95968824c16a)